Regulatory failure of serum prohepcidin levels in patients with hepatitis C

Hepatology Research

Volumn 36, Issue 4, 2006, Pages 288-293

  Nagashima, Miki ^a   Kudo, Masatoshi ^a   Chung, Hobyung ^a   Ishikawa, Emi ^a   Hagiwara, Satoru ^a   Nakatani, Tatsuya ^a   Dote, Kensaku ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Chronic viral hepatitis; Ferritin; Hepatitis C; Hepcidin; Iron overload; Serum prohepcidin

Indexed keywords

FERRITIN; HEPCIDIN; IRON;

ADOLESCENT; ADULT; AGED; ARTICLE; CHRONIC HEPATITIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; DISEASE MARKER; FEMALE; FERRITIN BLOOD LEVEL; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HOMEOSTASIS; HUMAN; HUMAN TISSUE; IRON BLOOD LEVEL; IRON OVERLOAD; LIVER CIRRHOSIS; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REGULATORY MECHANISM; TISSUE SECTION;

EID: 33750887806     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hepres.2006.08.006     Document Type: Article

References (25)

1. Koziel M.J. The role of immune responses in the pathogenesis of hepatitis C virus infection. J Viral Hepat 4 Suppl 2 (1997) 31-41
2. Piperno A., D'Alba R., Fargion S., et al. Liver iron concentration in chronic viral hepatitis: A study of 98 patients. Eur J Gastroenterol Hepatol 7 (1995) 1203-1208
3. Di Bisceglie A.M., Axiotis C.A., Hoofnagle J.H., et al. Measurements of iron status in patients with chronic hepatitis. Gastroenterology 102 (1992) 2108-2113
4. Barton A.L., Banner B.F., Cable E.E., et al. Distribution of iron in the liver predicts the response of chronic hepatitis C infection to interferon therapy. Am J Clin Pathol 103 (1995) 419-424
5. Fargion S., Fracanzani A.L., Sampietro M., et al. Liver iron influences the response to interferon alpha therapy in chronic hepatitis C. Eur J Gastroenterol Hepatol 9 (1997) 497-503
6. Ikura Y., Morimoto H., Johmura H., et al. Relationship between hepatic iron deposits and response to interferon in chronic hepatitis C. Am J Gastroenterol 91 (1996) 1367-1373
7. Olynyk J.K., Reddy K.R., Di Bisceglie A.M., et al. Hepatic iron concentration as a predictor of response to interferon alfa therapy in chronic hepatitis C. Gastroenterology 108 (1995) 1104-1109
8. Piperno A., Sampietro M., D'Alba R., et al. Iron stores, response to alpha interferon therapy, and effects of iron depletion in chronic hepatitis C. Liver 16 (1996) 248-254
9. Van Thiel D.H., Friedlander L., Fagiuoli S., et al. Response to interferon alpha therapy is influenced by the iron content of the liver. J Hepatol 20 (1994) 410-415
10. Hayashi H., Takikawa T., Nishimura N., et al. Improvement of serum aminotransferase levels after phlebotomy in patients with chronic active hepatitis C and excess hepatic iron. Am J Gastroenterol 89 (1994) 986-988
11. Kulaksiz H., Gehrke S.G., Janetzko A., et al. Pro-hepcidin: Expression and cell specific localization in the liver and its regulation in hereditary haemochromatosis, chronic renal insufficiency, and renal anaemia. Gut 53 (2004) 735-743
12. Park C.H., Valore E.V., Waring A.J., et al. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 276 (2001) 7806-7810
13. Fleming R.E., and Sly W.S. Hepcidin: A putative iron-regulatory hormone relevant to hereditary hemochromatosis and the anemia of chronic disease. Proc Natl Acad Sci USA 98 (2001) 8160-8162
14. Ganz T. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood 102 (2003) 783-788
15. Nemeth E., Valore E.V., Territo M., Schiller G., Lichtenstein A., and Ganz T. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood 101 (2003) 2461-2463
16. Nicolas G., Bennoun M., Devaux I., et al. Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc Natl Acad Sci USA 98 (2001) 8780-8785
17. Weinstein D.A., Roy C.N., Fleming M.D., et al. Inappropriate expression of hepcidin is associated with iron refractory anemia: Implications for the anemia of chronic disease. Blood 100 (2002) 3776-3781
18. Gehrke S.G., Kulaksiz H., Herrmann T., et al. Expression of hepcidin in hereditary hemochromatosis: Evidence for a regulation in response to the serum transferrin saturation and to non-transferrin-bound iron. Blood 102 (2003) 371-376
19. Aoki C.A., Rossaro L., Ramsamooj R., et al. Liver hepcidin mRNA correlates with iron stores, but not inflammation, in patients with chronic hepatitis C. J Clin Gastroenterol 39 (2005) 71-74
20. Krause A., Neitz S., Magert H.J., et al. LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett 480 (2000) 147-150
21. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group. Hepatology 1994;20:15-20.
22. Deuguier Y.M., Turlin B., Powell L.W., et al. Differentiation between heterozygotes and homozygotes in genetic hemochromatosis by means of a histological hepatic iron index: A study of 192 cases. Hepatology 17 1 (1993) 30-34
23. Pigeon C., Ilyin G., Courselaud B., et al. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem 276 (2001) 7811-7819
24. Kulaksiz H., Theilig F., Bachmann S., et al. The iron-regulatory peptide hormone hepcidin: Expression and cellular localization in the mammalian kidney. J Endocrinal 184 (2005) 361-370
25. Ohtake T., Ikuta K., Saitou H., et al. Mechanism of iron uptake through serum transferring and influence of oxidative stress in hepatocytes. In: Tanikawa K. (Ed). Oxidative Stress and Liver Disease (2005), Arc Medium, Co., Ltd., Japan 85-93